• Latest Posts

The UK-Israeli €378M Small-Molecule Offensive Against Migraines

“The Next Generation of Biologicals will be Cell-based”

Aquanos Algae: Israeli Start-up fixes the Global Sustainability issue in Recycling Sewage Water

No, Novartis and Roche won’t merge (yet)!

Why can’t Novartis Commit to the Israeli Biotech Scene?

iGEM 2015: Europe still dominates World’s Largest Synthetic Biology Contest

ADVERTISEMENT

NovoCure, the Israeli tumor specialist announces NASDAQ €170M IPO

Gut bacteria growth time can cause disease?

Kamada and Baxter extend their collaboration in Lung Transplant

After two failed IPOs, Mapi Pharma raised €9 Million from private investors

CRISPR-armed Viruses to kill Antibiotic-Resistant Bacteria

Pluristem accelerates its Cell Therapy program thanks to the EMA

ADVERTISEMENT